ChemicalBook >> CAS DataBase List >>GSK-626616
GSK-626616
- CAS No.
- 1025821-33-3
- Chemical Name:
- GSK-626616
- Synonyms
- GSK-626616;(5Z)-2-[(2,6-Dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-4(5H)-thiazolone;(Z)-2-((2,6-Dichlorophenyl)amino)-5-(quinoxalin-6-ylmethylene)thiazol-4(5H)-one;4(5H)-Thiazolone, 2-[(2,6-dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-, (5Z)-;GSK 626616,DYRK,Inhibitor,Dual specificity tyrosine regulated kinase,GSK-626616,GSK626616,inhibit,Dual specificity tyrosine phosphorylation regulated kinase
- CBNumber:
- CB63303333
- Molecular Formula:
- C18H10Cl2N4OS
- Molecular Weight:
- 401.27
- MDL Number:
- MFCD31689261
- MOL File:
- 1025821-33-3.mol
Last updated:2024-11-19 23:02:33
Melting point | 281 - 282oC |
---|---|
Boiling point | 574.8±60.0 °C(Predicted) |
Density | 1.55±0.1 g/cm3(Predicted) |
storage temp. | Refrigerator, under inert atmosphere |
solubility | Chloroform (Slightly, Heated), Methanol (Slightly) |
pka | -0.94±0.20(Predicted) |
form | Solid |
color | Pale Yellow to Light Yellow |
FDA UNII | OKY0RM282V |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H319-H335-H302-H315 | |||||||||
Precautionary statements | P264-P270-P301+P312-P330-P501-P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P | |||||||||
NFPA 704 |
|
GSK-626616 price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich | SML3355 | GSK626616 ≥98% (HPLC) | 1025821-33-3 | 5MG | $87 | 2024-03-01 | Buy |
Sigma-Aldrich | SML3355 | GSK626616 ≥98% (HPLC) | 1025821-33-3 | 25MG | $350 | 2024-03-01 | Buy |
Tocris | 6638 | GSK626616 ≥98%(HPLC) | 1025821-33-3 | 50 | $861 | 2021-12-16 | Buy |
Tocris | 6638 | GSK626616 ≥98%(HPLC) | 1025821-33-3 | 10 | $205 | 2021-12-16 | Buy |
TRC | G797853 | GSK-626616 | 1025821-33-3 | 10mg | $160 | 2021-12-16 | Buy |
GSK-626616 Chemical Properties,Uses,Production
Uses
GSK-626616 is a potent and selective DYRK inhibitor (IC50 = 0.7 nM for DYRK3, similar potency for DYRK1 and 2). Exhibits ~20-fold selectivity over casein kinase 2 and negligible activity against a panel of 451 kinases screened. Enhances number of CFU-E stimulated by Epo from human marrow. Increases hemoglobin levels in anemic mice. Orally bioavailable.
storage
Store at +4°C
GSK-626616 Preparation Products And Raw materials
Raw materials
Preparation Products
GSK-626616 Suppliers
Global( 34)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32957 | 60 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32165 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6391 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49734 | 58 |
LEAPCHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 43340 | 58 |
Aladdin Scientific | +1-+1(833)-552-7181 | sales@aladdinsci.com | United States | 57505 | 58 |
Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131957 | 58 |
Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9806 | 58 |
Shanghai SuperLan Chemcial Technique Centre | 021-2022843681 15618226720 | lucy@atkchemical.com | China | 10270 | 58 |
Nanjing Meihao Pharmaceutical Technology Co., Ltd. | meitaochem@126.com | meitaochem@126.com | China | 19103 | 58 |
View Lastest Price from GSK-626616 manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
2024-11-19 | GSK-626616
1025821-33-3
|
US $44.00-155.00 / mg | 99.48% | 10g | TargetMol Chemicals Inc. |
- GSK-626616
1025821-33-3
- US $44.00-155.00 / mg
- 99.48%
- TargetMol Chemicals Inc.
GSK-626616
(5Z)-2-[(2,6-Dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-4(5H)-thiazolone
4(5H)-Thiazolone, 2-[(2,6-dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-, (5Z)-
GSK 626616,DYRK,Inhibitor,Dual specificity tyrosine regulated kinase,GSK-626616,GSK626616,inhibit,Dual specificity tyrosine phosphorylation regulated kinase
(Z)-2-((2,6-Dichlorophenyl)amino)-5-(quinoxalin-6-ylmethylene)thiazol-4(5H)-one
1025821-33-3